Houlihan Lokey Advises MedPartners

Transaction: Houlihan Lokey Advises MedPartners

Houlihan Lokey is pleased to announce the sale of MedPartners to AMN Healthcare (NYSE:AMN) for $215 million. The transaction was announced and closed on April 9, 2018.

MedPartners, based in Tampa, Florida, provides solutions that help maximize healthcare facilities' revenue integrity, improve patient care management, and support care-quality reporting requirements. The purchase price was $195 million, with up to an additional $20 million based on future financial performance. MedPartners generated 2017 revenue of approximately $125 million with an adjusted EBITDA margin of 16%. The MedPartners acquisition is expected to be immediately accretive to AMN's earnings per share.

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare's workforce solutions—including managed services programs, vendor management systems, recruitment process outsourcing, and consulting services—enable providers to successfully reduce complexity, increase efficiency, and improve patient outcomes within the rapidly evolving healthcare environment.

Houlihan Lokey served as the exclusive financial advisor to MedPartners. Houlihan Lokey's Human Capital Management (HCM) team is among the most active M&A advisors in the market, having closed nine HCM transactions in the past 12 months and 25 HCM transactions since October 2014 with an aggregate enterprise value of more than $3.7 billion. This most recent transaction further strengthens Houlihan Lokey's leadership in the business services universe and highlights continued momentum and leadership in the HCM sector, which includes staffing, recruitment, VMS, MSP, RPO, and PEO.

View All Transactions